{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:06:30Z","timestamp":1790658390223,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,16]],"date-time":"2018-07-16T00:00:00Z","timestamp":1531699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Metastatic lung cancer is the leading cause of cancer-associated mortality worldwide, therefore necessitating novel approaches to identify specific genetic drivers for lung cancer progression and metastasis. We recently performed an in vivo gain-of-function genetic screen to identify driver genes of lung cancer metastasis. In the study reported here, we identify\n                    <jats:italic>TMEM106B<\/jats:italic>\n                    as a primary robust driver of lung cancer metastasis. Ectopic expression of\n                    <jats:italic>TMEM106B<\/jats:italic>\n                    could significantly promote the synthesis of enlarged vesicular lysosomes that are laden with elevated levels of active cathepsins. In a\n                    <jats:italic>TFEB<\/jats:italic>\n                    -dependent manner,\n                    <jats:italic>TMEM106B<\/jats:italic>\n                    could modulate the expression of lysosomal genes of the coordinated lysosomal expression and regulation (CLEAR)\u00a0pathway in lung cancer cells and patient samples. We also demonstrate that\n                    <jats:italic>TMEM106B<\/jats:italic>\n                    -induced lysosomes undergo calcium-dependent exocytosis, thereby releasing active lysosomal cathepsins necessary for\n                    <jats:italic>TMEM106B<\/jats:italic>\n                    -mediated cancer cell invasion and metastasis in vivo, which could be therapeutically prevented by pharmacological inhibition of cathepsins. Further, in TCGA LUAD data sets, 19% of patients show elevated expression of\n                    <jats:italic>TMEM106B<\/jats:italic>\n                    , which predicts for poor disease-free and overall-survival.\n                  <\/jats:p>","DOI":"10.1038\/s41467-018-05013-x","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T05:35:27Z","timestamp":1531200927000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins"],"prefix":"10.1038","volume":"9","author":[{"given":"Samrat T.","family":"Kundu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin L.","family":"Grzeskowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared J.","family":"Fradette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia B.","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad J.","family":"Creighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don L.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,16]]},"reference":[{"key":"5013_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA Cancer J. Clin. 64, 9\u201329 (2014).","journal-title":"CA Cancer J. Clin."},{"key":"5013_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ccr.2011.05.025","volume":"20","author":"KL Scott","year":"2011","unstructured":"Scott, K. L. et al. Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell 20, 92\u2013103 (2011).","journal-title":"Cancer Cell"},{"key":"5013_CR3","doi-asserted-by":"publisher","first-page":"5341","DOI":"10.1158\/0008-5472.CAN-15-1654","volume":"75","author":"T Dogruluk","year":"2015","unstructured":"Dogruluk, T. et al. Identification of variant-specific functions of PIK3CA by rapid phenotyping of rare mutations. Cancer Res. 75, 5341\u20135354 (2015).","journal-title":"Cancer Res."},{"key":"5013_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10500","volume":"7","author":"YH Tsang","year":"2016","unstructured":"Tsang, Y. H. et al. Functional annotation of rare gene aberration drivers of pancreatic cancer. Nat. Commun. 7, 10500 (2016).","journal-title":"Nat. Commun."},{"key":"5013_CR5","doi-asserted-by":"publisher","unstructured":"Grzeskowiak, C. L. et al. In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer. Nat. Commun.\n                           https:\/\/doi.org\/10.1038\/s41467-018-04572-3 (2018).","DOI":"10.1038\/s41467-018-04572-3"},{"key":"5013_CR6","doi-asserted-by":"publisher","first-page":"3170","DOI":"10.1172\/JCI63608","volume":"122","author":"YH Ahn","year":"2012","unstructured":"Ahn, Y. H. et al. ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. J. Clin. Invest. 122, 3170\u20133183 (2012).","journal-title":"J. Clin. Invest."},{"key":"5013_CR7","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1101\/gad.1820209","volume":"23","author":"DL Gibbons","year":"2009","unstructured":"Gibbons, D. L. et al. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression. Genes Dev. 23, 2140\u20132151 (2009).","journal-title":"Genes Dev."},{"key":"5013_CR8","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1172\/JCI72171","volume":"124","author":"Y Yang","year":"2014","unstructured":"Yang, Y. et al. ZEB1 sensitizes lung adenocarcinoma to metastasis suppression by PI3K antagonism. J. Clin. Invest. 124, 2696\u20132708 (2014).","journal-title":"J. Clin. Invest."},{"key":"5013_CR9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00401-014-1249-3","volume":"127","author":"Y Deming","year":"2014","unstructured":"Deming, Y. & Cruchaga, C. TMEM106B: a strong FTLD disease modifier. Acta Neuropathol. 127, 419\u2013422 (2014).","journal-title":"Acta Neuropathol."},{"key":"5013_CR10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/alzrt247","volume":"6","author":"J Satoh","year":"2014","unstructured":"Satoh, J. et al. TMEM106B expression is reduced in Alzheimer\u2019s disease brains. Alzheimers Res. Ther. 6, 17 (2014).","journal-title":"Alzheimers Res. Ther."},{"key":"5013_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1007\/s12031-011-9555-x","volume":"45","author":"J van der Zee","year":"2011","unstructured":"van der Zee, J. & Van Broeckhoven, C. TMEM106B a novel risk factor for frontotemporal lobar degeneration. J. Mol. Neurosci. 45, 516\u2013521 (2011).","journal-title":"J. Mol. Neurosci."},{"key":"5013_CR12","doi-asserted-by":"crossref","unstructured":"Wood, H. B. TMEM106Bis a susceptibility locus for FTLD. Nat. Rev. Neurol. 6, 184 (2010).","DOI":"10.1038\/nrneurol.2010.22"},{"key":"5013_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/embj.201385857","volume":"33","author":"BM Schwenk","year":"2014","unstructured":"Schwenk, B. M. et al. The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes. EMBO J. 33, 450\u2013467 (2014).","journal-title":"EMBO J."},{"key":"5013_CR14","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.mcn.2014.07.006","volume":"61","author":"M Stagi","year":"2014","unstructured":"Stagi, M., Klein, Z. A., Gould, T. J., Bewersdorf, J., & Strittmatter, S. M. Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B. Mol. Cell Neurosci. 61, 226\u2013240 (2014).","journal-title":"Mol Cell Neurosci"},{"key":"5013_CR15","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1073\/pnas.091479298","volume":"98","author":"G Motyckova","year":"2001","unstructured":"Motyckova, G. et al. Linking osteopetrosis and pycnodysostosis: regulation of cathepsin K expression by the microphthalmia transcription factor family. Proc. Natl. Acad. Sci. USA 98, 5798\u20135803 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"5013_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1358\/dnp.2004.17.1.829022","volume":"17","author":"BR Troen","year":"2004","unstructured":"Troen, B. R. The role of cathepsin K in normal bone resorption. Drug News Perspect. 17, 19\u201328 (2004).","journal-title":"Drug News Perspect."},{"key":"5013_CR17","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1016\/j.febslet.2009.10.021","volume":"584","author":"T Kolter","year":"2010","unstructured":"Kolter, T. & Sandhoff, K. Lysosomal degradation of membrane lipids. FEBS Lett. 584, 1700\u20131712 (2010).","journal-title":"FEBS Lett."},{"key":"5013_CR18","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1016\/j.bbamcr.2008.09.020","volume":"674-683","author":"H Schulze","year":"1793","unstructured":"Schulze, H., Kolter, T. & Sandhoff, K. Principles of lysosomal membrane degradation: cellular topology and biochemistry of lysosomal lipid degradation. Biochim. Biophys. Acta 1793, 674-683 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"5013_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.bbamcr.2008.12.022","volume":"1793","author":"PR Pryor","year":"2009","unstructured":"Pryor, P. R. & Luzio, J. P. Delivery of endocytosed membrane proteins to the lysosome. Biochim. Biophys. Acta 1793, 615\u2013624 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"5013_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrm2745","volume":"10","author":"P Saftig","year":"2009","unstructured":"Saftig, P. & Klumperman, J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat. Rev. Mol. Cell Biol. 10, 623\u2013635 (2009).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"5013_CR21","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1158\/0008-5472.CAN-05-0476","volume":"65","author":"N Fehrenbacher","year":"2005","unstructured":"Fehrenbacher, N. & Jaattela, M. Lysosomes as targets for cancer therapy. Cancer Res. 65, 2993\u20132995 (2005).","journal-title":"Cancer Res."},{"key":"5013_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ceb.2016.02.009","volume":"39","author":"S Hamalisto","year":"2016","unstructured":"Hamalisto, S., & Jaattela, M. Lysosomes in cancer-living on the edge (of the cell). Curr. Opin. Cell Biol. 39, 69\u201376 (2016).","journal-title":"Curr Opin Cell Biol"},{"key":"5013_CR23","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/onc.2012.292","volume":"32","author":"T Kallunki","year":"2013","unstructured":"Kallunki, T., Olsen, O. D. & Jaattela, M. Cancer-associated lysosomal changes: friends or foes? Oncogene 32, 1995\u20132004 (2013).","journal-title":"Oncogene"},{"key":"5013_CR24","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/nrc4027","volume":"15","author":"OC Olson","year":"2015","unstructured":"Olson, O. C. & Joyce, J. A. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat. Rev. Cancer 15, 712\u2013729 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"5013_CR25","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.molonc.2014.07.004","volume":"8","author":"DM Brix","year":"2014","unstructured":"Brix, D. M. et al. Screening and identification of small molecule inhibitors of ErbB2-induced invasion. Mol. Oncol. 8, 1703\u20131718 (2014).","journal-title":"Mol Oncol"},{"key":"5013_CR26","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.devcel.2011.07.016","volume":"21","author":"DL Medina","year":"2011","unstructured":"Medina, D. L. et al. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev. Cell 21, 421\u2013430 (2011).","journal-title":"Dev Cell"},{"key":"5013_CR27","first-page":"871","volume":"6","author":"KB Atkins","year":"1995","unstructured":"Atkins, K. B. & Troen, B. R. Regulation of cathepsin D gene expression in HL-60 cells by retinoic acid and calcitriol. Cell Growth Differ. 6, 871\u2013877 (1995).","journal-title":"Cell Growth Differ."},{"key":"5013_CR28","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1006\/bbrc.2001.5127","volume":"285","author":"S Corisdeo","year":"2001","unstructured":"Corisdeo, S., Gyda, M., Zaidi, M., Moonga, B. S., & Troen, B. R. New insights into the regulationof cathepsin K gene expression by osteoprotegerin ligand. Biochem. Biophys. Res. Commun. 285, 335\u2013339 (2001).","journal-title":"Biochem Biophys Res Commun"},{"key":"5013_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1196\/annals.1346.018","volume":"1068","author":"BR Troen","year":"2006","unstructured":"Troen, B. R. The regulation of cathepsin K gene expression. Ann. N. Y. Acad. Sci. 1068, 165\u2013172 (2006).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"5013_CR30","doi-asserted-by":"publisher","first-page":"7670","DOI":"10.1158\/0008-5472.CAN-11-0964","volume":"71","author":"MJ Schliekelman","year":"2011","unstructured":"Schliekelman, M. J. et al. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res. 71, 7670\u20137682 (2011).","journal-title":"Cancer Res."},{"key":"5013_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0014-5793(93)80643-9","volume":"332","author":"V Dalet-Fumeron","year":"1993","unstructured":"Dalet-Fumeron, V., Guinec, N. & Pagano, M. In vitro activation of pro-cathepsin B by three serine proteinases: leucocyte elastase, cathepsin G, and the urokinase-type plasminogen activator. FEBS Lett. 332, 251\u2013254 (1993).","journal-title":"FEBS Lett."},{"key":"5013_CR32","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.ajpath.2012.08.027","volume":"181","author":"M Yin","year":"2012","unstructured":"Yin, M. et al. TGF-beta signaling, activated stromal fibroblasts, and cysteine cathepsins B and L drive the invasive growth of human melanoma cells. Am. J. Pathol. 181, 2202\u20132216 (2012).","journal-title":"Am J Pathol"},{"key":"5013_CR33","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/ncb3011","volume":"16","author":"L Sevenich","year":"2014","unstructured":"Sevenich, L. et al. Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S. Nat. Cell Biol. 16, 876\u2013888 (2014).","journal-title":"Nat. Cell Biol."},{"key":"5013_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1535-6108(04)00111-4","volume":"5","author":"JA Joyce","year":"2004","unstructured":"Joyce, J. A. et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell. 5, 443\u2013453 (2004).","journal-title":"Cancer Cell."},{"key":"5013_CR35","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1101\/gad.249599.114","volume":"28","author":"L Akkari","year":"2014","unstructured":"Akkari, L. et al. Distinct functions of macrophage-derived and cancer cell-derived cathepsin Z combine to promote tumor malignancy via interactions with the extracellular matrix. Genes Dev. 28, 2134\u20132150 (2014).","journal-title":"Genes Dev."},{"key":"5013_CR36","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1038\/sj.onc.1210493","volume":"26","author":"S Zheng","year":"2007","unstructured":"Zheng, S., El-Naggar, A. K., Kim, E. S., Kurie, J. M. & Lozano, G. A genetic mouse model for metastatic lung cancer with gender differences in survival. Oncogene 26, 6896\u20136904 (2007).","journal-title":"Oncogene"},{"key":"5013_CR37","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/2051-5960-1-36","volume":"1","author":"JI Busch","year":"2013","unstructured":"Busch, J. I. et al. Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain. Acta Neuropathol. Commun. 1, 36 (2013).","journal-title":"Acta Neuropathol. Commun."},{"key":"5013_CR38","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1523\/JNEUROSCI.0521-12.2012","volume":"32","author":"AS Chen-Plotkin","year":"2012","unstructured":"Chen-Plotkin, A. S. et al. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132\/212 cluster and affects progranulin pathways. J. Neurosci. 32, 11213\u201311227 (2012).","journal-title":"J Neurosci"},{"key":"5013_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1083\/jcb.137.1.93","volume":"137","author":"A Rodriguez","year":"1997","unstructured":"Rodriguez, A., Webster, P., Ortego, J. & Andrews, N. W. Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J. Cell Biol. 137, 93\u2013104 (1997).","journal-title":"J. Cell Biol."},{"key":"5013_CR40","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1242\/jcs.146365","volume":"129","author":"G Napolitano","year":"2016","unstructured":"Napolitano, G. & Ballabio, A. TFEB at a glance. J. Cell Sci. 129, 2475\u20132481 (2016).","journal-title":"J. Cell Sci."},{"key":"5013_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nyas.13131","volume":"1371","author":"M Sardiello","year":"2016","unstructured":"Sardiello, M. Transcription factor EB: from master coordinator of lysosomal pathways to candidate therapeutic target in degenerative storage diseases. Ann. N. Y. Acad. Sci. 1371, 3\u201314 (2016).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"5013_CR42","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","volume":"332","author":"C Settembre","year":"2011","unstructured":"Settembre, C. et al. TFEB links autophagy to lysosomal biogenesis. Science 332, 1429\u20131433 (2011).","journal-title":"Science"},{"key":"5013_CR43","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).","journal-title":"Sci. Signal."},{"key":"5013_CR44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401\u2013404 (2012).","journal-title":"Cancer Discov."},{"key":"5013_CR45","doi-asserted-by":"crossref","unstructured":"Nicholson, A. M. & Rademakers, R. What we know about TMEM106B in neurodegeneration. Acta Neuropathol. 132, 639 (2016).","DOI":"10.1007\/s00401-016-1610-9"},{"key":"5013_CR46","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1126\/science.1174447","volume":"325","author":"M Sardiello","year":"2009","unstructured":"Sardiello, M. et al. A gene network regulating lysosomal biogenesis and function. Science 325, 473\u2013477 (2009).","journal-title":"Science"},{"key":"5013_CR47","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4161\/cc.6.1.3669","volume":"6","author":"V Gocheva","year":"2007","unstructured":"Gocheva, V. & Joyce, J. A. Cysteine cathepsins and the cutting edge of cancer invasion. Cell Cycle 6, 60\u201364 (2007).","journal-title":"Cell Cycle"},{"key":"5013_CR48","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/onc.2015.71","volume":"35","author":"ST Kundu","year":"2016","unstructured":"Kundu, S. T. et al. The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers. Oncogene 35, 173\u2013186 (2016).","journal-title":"Oncogene"},{"key":"5013_CR49","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1038\/onc.2016.303","volume":"36","author":"F Chen","year":"2017","unstructured":"Chen, F. et al. Multiplatform-based molecular subtypes of non-small-cell lung cancer. Oncogene. 36, 1384\u20131393 (2017).","journal-title":"Oncogene"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05013-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T10:53:55Z","timestamp":1671533635000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05013-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["5013"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-05013-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,16]]},"assertion":[{"value":"7 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2731"}}